The above outcomes suggested that Ang II might promote the assembly of NLRP3 inflammasome in macrophages and IL-1β release through angiotensin II type 1 (AT1) receptor or the mtROS-dependent pathway, leading to the generation of inflammation in the early stage of AAA [43]. Here, NLRP3 is linked to triple-A syndrome.